Back
Lantern Pharma Stock Predictions
Your Summer Trading Shortcut
Try it free today.
Sell
41
LTRN
Lantern Pharma
Last Price:
$3.28
Seasonality Move:
-1.69%
7 Day Trial
ALL ACCESS PASS
$
7
Built for Lazy Summer Markets
Get instant access today.Lantern Pharma Stock Forecast
-
Is Lantern Pharma Stock Undervalued?The current Lantern Pharma [LTRN] share price is $3.18. The Score for LTRN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
LTRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Lantern Pharma Stock Go Up Next Year?
Data Unavailable
Lantern Pharma Stock Rating
Data Unavailable
Lantern Pharma Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lanternpharma.com
52-Week Data
52-Week High:
6.12
52-Week Low:
2.55
Prediction Charts
Market Cap:
34.3M
Price in USD:
3.18
Volume:
45K
Beta:
1.57
Technical Analysis
SMA50:
3.42
SMA100:
3.64
SMA200:
3.65
52-Wk Change:
-27.73%
Stock Predictions
-
Is Lantern Pharma stock public?Yes, Lantern Pharma is a publicly traded company.
-
What is the Lantern Pharma stock quote today?The Lantern Pharma stock price is 3.18 USD today.
-
How to buy Lantern Pharma stock online?You can buy Lantern Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-12 | 3.33 | 3.23 | 3.58 | 3.21 |
| Jun-13 | 3.20 | 3.05 | 3.33 | 3.05 |
| Jun-16 | 3.10 | 3.20 | 3.33 | 3.08 |
| Jun-17 | 3.20 | 3.15 | 3.27 | 3.11 |
| Jun-18 | 3.21 | 3.18 | 3.24 | 3.09 |
| Jun-20 | 3.16 | 3.18 | 3.23 | 3.08 |
| Jun-23 | 3.09 | 3.07 | 3.16 | 3.01 |
| Jun-24 | 3.10 | 3.21 | 3.22 | 3.10 |
| Jun-25 | 3.19 | 3.11 | 3.22 | 3.05 |
| Jun-26 | 3.17 | 3.14 | 3.19 | 3.06 |
| Jun-27 | 3.17 | 3.19 | 3.22 | 3.05 |
| Jun-30 | 3.18 | 3.16 | 3.24 | 3.13 |
| Jul-1 | 3.14 | 3.15 | 3.31 | 3.09 |
| Jul-2 | 3.15 | 3.18 | 3.28 | 3.14 |
Lantern Pharma Earnings
Data Unavailable
Lantern Pharma Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.28 per share.
* Lantern Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.